Biolase inc.

BIOLASE, Inc. (NASDAQ:BIOL) issued its quarterly earnings data on Thursday, November, 9th. The medical technology company reported ($3.89) EPS for the quarter. The medical technology company earned $10.92 million during the quarter. BIOLASE had a negative trailing twelve-month return on equity of 503.34% and a negative net margin of 50.61%.

Biolase inc. Things To Know About Biolase inc.

BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group LLC under which the underwriters have agreed to purchase, on a firm commitment basis, 14,000,000 shares of common stock of the …LAKE FOREST, Calif., June 14, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced an arrangement with Pet Dental Services (PDS), the #1 non-anesthetic pet dental provider in the country, to integrate BIOLASE's diode laser technology. PDS' vision in the animal health care …BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit was $26.00 , which reflects the issuance of the Series H Convertible Preferred Stock with an original issue discount.Feb 6, 2021 · BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies ...

Charts. Forms. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….

Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2023, and to answer questions. To access the ...

Dr. Morrow brings extensive clinical, dental and DSO experience to help expand laser adoption globally. LAKE FOREST, Calif., Oct. 13, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the appointment of Russell Morrow, D.D.S. as Chief Dental Officer ("CDO"), effective …LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- Biolase Technology, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 ...About BIOLASE, Inc. BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 261 …LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J Convertible Redeemable …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

Q4 2022 Financial Results Conference Call. Mar 28, 2023 • 4:30 pm EDT. To access the call replay dial 877-481-4010 or +1 919-882-2331 (International) and enter replay passcode 47764. Earnings Release. PDF HTML.

Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued.BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit was $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.Nov 9, 2023 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2023, and to answer questions. To access the live call, dial 1-866-682-6100 (U.S.) or +1 862-298-0702 (International) and ask to join the BIOLASE call. If you have questions about how to vote your shares, or need additional assistance, please contact the firm assisting BIOLASE in the solicitation of proxies: Stockholders may call toll-free at 800-322-2885 Banks and brokers may call 212 -929-5500 Email: [email protected]. About BIOLASE, Inc.

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2023, and to answer questions. To access the live call, dial 1-877-545-0523 (U.S.) or +1 973-528-0016 (International) and provide the following code: 180082.BIOLASE, Inc. BIOLASE is revolutionizing surgery in dentistry and medicine with Waterlase technology. We specialize in the development, manufacturing and marketing of dental lasers….BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is ...BIOLASE, Inc. is a biomedical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers.BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its ...BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

About Biolase Inc. Biolase, Inc. develops, manufactures, and markets medical devices. The Company offers all and soft tissue dental lasers, as well as 3D intraoral scanner. Biolase serves ...BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including digital x …Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists …Biolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ...FOOTHILL RANCH, Calif., Jan. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced preliminary 2021 fourth quarter revenue results that are ...Dental laser interface system and method · Patent number: 11568978 · Abstract: Embodiments of the invention provide a system of controlling a dental laser ...FOOTHILL RANCH, Calif., Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by ...Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including …

BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable …LAKE FOREST, Calif., Oct. 27, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2022 financial and operating results on Thursday, November 10, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m ...BIOLASE Inc (BIOL) Stock Price & News - Google Finance Home BIOL • NASDAQ BIOLASE Inc Follow Share $1.15 Dec 1, 8:30:00 PM GMT-5 · USD · NASDAQ · …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…IRVINE, Calif., Jan. 20, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced a continuation of their collaboration with BMW Performance Center West (BMW PCW) at The Thermal Club near Palm Springs, to offer dentists the unique opportunity to experience two state-of-the-art pieces of technology; …View the latest Biolase Inc. (BIOL) stock price, news, historical charts, analyst ratings and financial information from WSJ.BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and …If you have questions about how to vote your shares, or need additional assistance, please contact the firm assisting BIOLASE in the solicitation of proxies: Stockholders may call toll-free at 800-322-2885 Banks and brokers may call 212 -929-5500 Email: [email protected]. About BIOLASE, Inc.

Innovative Technology Continues to be Recognized by Industry Peers. LAKE FOREST, Calif., July 17, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced that its Epic Hygiene dental laser, the only hygiene dental laser cleared by the U.S. Food and Drug Administration (FDA) for laser bacterial …BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed ...Mar 28, 2023 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2022, and to answer questions. To access the live call, dial 1-888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following code: 121864. Lincare Inc. sells oxygen and infusion systems for in-home respiratory therapy. Some of the oxygen systems include concentrators, portable and stationary liquid oxygen systems and high-pressure systems.Instagram:https://instagram. smart health insurance reviewsmarc chaikin stock picks todaymortgage backed securities todaye8 forex Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. nasdaq becntrlef Dentists & Laser Dentistry. BIOLASE dental laser technology is designed expressly for dental applications, such as cavity preparations, soft tissue surgeries, and much more. Learn why Waterlase is the essential dental laser solution for your practice. LEARN MORE. ijj stock Dentists & Laser Dentistry. BIOLASE dental laser technology is designed expressly for dental applications, such as cavity preparations, soft tissue surgeries, and much more. Learn why Waterlase is the essential dental laser solution for your practice. LEARN MORE.Apr 28, 2022 · COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022. LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today announced that it held its annual meeting of stockholders on April 28, 2022 where the Company's stockholders granted the Board of Directors the discretion to effect a reverse stock split of the Company's ...